CureMatch® CTO is co-author in Cancer Discovery Journal article showing computational modeling of drug resistance caused by gene mutations advances personalized cancer medicine. SAN DIEGO, CA – January 25, 2018: Igor F. Tsigelny, Ph.D., Co-founder and Chief Technology Officer at CureMatch and research professor at University of California, San Diego, is a co-author of “Genomic landscape […]
This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.